It was shown that higher NEDD9 levels were significantly correlated with clinical staging, lymph node metastasis and histological differentiation and patients with a higher NEDD9 expression had a significantly shorter survival time than those patients with lower NEDD9 expression. Here, NEDD9 is linked to metastatic malignant neoplasm in the lymph nodes.